Title: Family Medicine – Rheumatology: Rheumatoid Arthritis; Spondyloarthropothies; Scleroderma and Raynaud’s Disease
Faculty: William T. Ayoub, M.D., F.A.C.P., F.A.C.R., Lawrence H. Brent, M.D.
Original Release Date: July 1, 2018 Expiration Date: July 1, 2021
TOPIC 1: Rheumatoid Arthritis: Clinical Manifestations and Treatment.
Upon completion of this session, the participant should be able to: GL, COMP
- Specify the clinical features of rheumatoid arthritis.
- Illustrate the systemic nature of the disease.
- Summarize the use and toxicity of disease modifying agents as recommended by the American College of Rheumatology guidelines.
TOPIC 2: Spondyloarthropathies.
Upon completion of this session, the participant should be able to: EBM, COMP
- Distinguish the clinical features of the different spondyloarthropathies to improve diagnostic accuracy.
- Utilize clinical features, laboratory studies, and radiological studies to make a diagnosis of axial spondyloarthropathy.
- Prescribe pharmacologic agents according to ACR and EULAR recommendations and evidence-based results from clinical trials for patients with spondyloarthropathies.
TOPIC 3: Scleroderma and Raynaud’s Disease.
Upon completion of this session, the participant should be able to: GL, COMP
- Specify the clinical manifestations of scleroderma.
- Apply the ACR/EULAR classification criteria for systemic sclerosis.
- Utilize treatment available for symptomatic manifestations as per the current EULAR recommendations.
- Apply the diagnostic work-up and treatment of Raynaud’s Phenomenon.
- The receipt for any incentive-associated purchase will designate the value of the gift card separately from the cost of the learning activity.
- This incentive may have implications on your tax reporting obligations. Any reimbursed amount must be declared as personal income for tax purposes.